Most bought healthcare stocks in Q1 2020

See which Healthcare stocks institutional investors increased the most in Q1 2020, measured as net growth in reported share positions from Q4 2019 into Q1 2020. Notable additions at the top of this list include AGILENT TECHNOLOGIES INC (A), BOSTON SCIENTIFIC CORP (BSX), CENTENE CORP (CNC), PRECIGEN INC (PGEN). These rankings aggregate SEC 13F filings from all institutional investors in our database.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
AAGILENT TECHNOLOGIES INC13,646,246$14.12M22207
BSXBOSTON SCIENTIFIC CORP9,096,330$21.94M31125
CNCCENTENE CORP8,847,557$16.77M33117
PGENPRECIGEN INC8,345,086$28.37K30003
ABTABBOTT LABORATORIES8,267,720$57.19M335011
SDGRSCHRODINGER INC6,981,665$301.05K10001
CERSCERUS CORP4,560,330$25.27K01011
MRKMERCK & CO. INC.2,937,869$148.33M277019
PACBPACIFIC BIOSCIENCES OF CALIF2,683,645$4.74K01002
BDXBECTON DICKINSON AND CO2,602,647$46.30M434112
ABBVABBVIE INC2,574,976$41.67M334011
NVSTENVISTA HOLDINGS CORP2,456,573$1.56M20012
AMRNAMARIN CORP PLC -ADR2,370,355$8.60K11002
HCAHCA HEALTHCARE INC2,160,695$9.23M31105
EXELEXELIXIS INC2,153,218$29.90K11002
XRAYDENTSPLY SIRONA INC1,663,934$14.19M22105
EHCENCOMPASS HEALTH CORP1,632,431$104.39K20103
NVONOVO-NORDISK A/S-SPONS ADR1,524,391$152.87K01011
NTLAINTELLIA THERAPEUTICS INC1,461,154-$3.55K01011
TAKTAKEDA PHARMACEUTIC-SP ADR1,426,280$1.13K01102
INCYINCYTE CORP1,373,760$2.97M14005
MCRBSERES THERAPEUTICS INC1,334,871$5.77K01102
HUMHUMANA INC1,240,851$29.45M12124
PBYIPUMA BIOTECHNOLOGY INC994,013$32.95K11002
AUPHAURINIA PHARMACEUTICALS INC983,954$1.49M12003
HSICHENRY SCHEIN INC927,221$4.09M21104
EDITEDITAS MEDICINE INC886,242-$33.90K02103
HRTXHERON THERAPEUTICS INC870,892$8.10K01001
VXRTVAXART INC803,954$3.37K01001
WSTWEST PHARMACEUTICAL SERVICES757,198$1.57M20103
IRWDIRONWOOD PHARMACEUTICALS INC744,763$5.09K01001
MTNBMATINAS BIOPHARMA HOLDINGS I726,358-$6101001
SNNSMITH & NEPHEW PLC -SPON ADR721,250$25.87K10001
OCGNOCUGEN INC675,514$18701001
PCRXPACIRA BIOSCIENCES INC670,804$1.34K01001
GRFSGRIFOLS SA-ADR667,751-$27.18K01102
ALGNALIGN TECHNOLOGY INC657,789$5.18M23227
SAGESAGE THERAPEUTICS INC636,541$13.47K01001
AMGNAMGEN INC630,543$50.56M324011
ZBHZIMMER BIOMET HOLDINGS INC592,165$8.63M23116
CTLTCATALENT INC574,005$22.62K02103
CPRXCATALYST PHARMACEUTICALS INC563,526$2.19K01001
ELANELANCO ANIMAL HEALTH INC554,759$3.87M22004
OMIOWENS & MINOR INC538,250$14.85K01001
CORTCORCEPT THERAPEUTICS INC534,627$4.73K01001
ALDXALDEYRA THERAPEUTICS INC517,200$1.01K01001
THCTENET HEALTHCARE CORP511,200$6.69K01001
EXASEXACT SCIENCES CORP493,526$1.91M21003
PSNLPERSONALIS INC478,209$2.09K01001
VCYTVERACYTE INC477,423$1.54K01001
Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.0.003.8M7.5M11.3M15.0MNet change in reported shares (all institutional filers)ABSXCNCPGENABTSDGRCERSMRKPACBBDXABBVNVSTAMRNHCAEXELXRAYEHCNVONTLATAKSymbol

Frequently asked questions about Most bought healthcare stocks in Q1 2020

  • What are the most bought Healthcare stocks in Q1 2020?

    The most bought healthcare stocks in Q1 2020 are those with the largest increase in reported share counts across institutional investors compared to Q4 2019, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q1 2020?

    Among filers in this sector, net additions were largest in companies such as AGILENT TECHNOLOGIES INC (A), BOSTON SCIENTIFIC CORP (BSX), CENTENE CORP (CNC), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2019).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.